Medicaid-enrolled youth aged 5 to 24 years who begin taking high doses of antipsychotics for psychia...

Children who have an older sibling who has been diagnosed with autism spectrum disorder (ASD) are no...

The Food and Drug Administration has approved Jornay PM (extended-release methylphenidate capsules) ...

Welcome to New York City! APA’s 2018 Annual Meeting began in New York today. From now through May 9,...

Stimulants are a preferred option for treating attention-deficit/hyperactivity disorder (ADHD), but ...

Although some patients who screen positive for attention-deficit/hyperactivity disorder (ADHD) in ad...

Adolescents with more severe symptoms of attention-deficit/hyperactivity disorder (ADHD)—particularl...

People with attention-deficit/hyperactivity disorder (ADHD) are known to be at a higher risk of car ...

Researchers have developed an updated screening scale for diagnosing adults with attention-deficit/h...